Sign in to view content

Geographic Atrophy in the Canadian Treat and Extend Trial With Ranibizumab in nAMD Patients: CANTREAT Study 24-Month Results

Peter J. Kertes, MD, FRCS(C)

Video
Published 2019

Peter J. Kertes, MD, FRCS(C)

AMD Neovascular Part II Symposium

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more